Trials / Completed
CompletedNCT00366158
EVITA: Evaluation of VIP Feature in Pacemaker Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 461 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary efficacy objective of this clinical investigation is to demonstrate that the Ventricular Intrinsic Preference (VIP™) feature allows to reduce the medium- and long-term incidence of unnecessary ventricular pacing in patients with intact AV conduction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device: St. Jude Medical Victory dual-chamber pacemaker | Pacemaker implant |
| DEVICE | Ventricular Intrinsic Preference | Programming of pacemaker |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2009-06-01
- Completion
- 2010-09-01
- First posted
- 2006-08-21
- Last updated
- 2019-02-04
Locations
2 sites across 2 countries: Germany, Sweden
Source: ClinicalTrials.gov record NCT00366158. Inclusion in this directory is not an endorsement.